BioHarvest Sciences Inc. (BHST) vs Harte Hanks, Inc. (HHS)

A side-by-side comparison of BioHarvest Sciences Inc. and Harte Hanks, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BHST vs HHS

growth of $100 · dividends reinvested · last 2y
BHST -70.6% (-45.8%/yr)HHS -36.6% (-20.4%/yr)HHS compounded faster over this window
50100150200250Start $10020252026$29$63
BHST HHS

BHST vs HHS: by the numbers

  • •HHS is the larger company ($33M vs $26M market cap).
  • •Both run net losses; HHS's is the smaller (-3.70% vs -31.21% net margin).
  • •BHST grew revenue faster over the past five years (102.48% vs -3.81% CAGR).

Metrics side by side

Valuation

MetricBHSTHHS
P/S ratio0.730.22
P/B ratio1.322.18
EV / EBITDAN/A82.01

Profitability

MetricBHSTHHS
Gross margin58.95%68.73%
Operating margin-17.99%-2.53%
Net margin-31.21%-3.70%
ROE-56.03%-37.23%
ROIC-17.10%-6.96%

Growth (annualized)

MetricBHSTHHS
Revenue CAGR (5Y)102.48%-3.81%
Total return CAGR (5Y)N/A-10.05%

Frequently asked

Which has grown faster, BHST or HHS?
Over the past five years, BHST grew revenue faster — BHST at a 102.48% CAGR versus HHS at -3.81%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.